Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb ...

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology firm specializing in regenerative medicine with a market capitalization of approximately $7 million, has revealed promising one-year follow-up ...

There isn't a cure for the condition, but doctors may recommend medications to slow down the progression of the disease or ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

If you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know ...

Millions with type 2 diabetes face hidden nutrient deficiencies, raising concerns about health risks and the urgent need for dietary intervention.

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...